Gut, oral and nasal microbiota and Parkinson’s disease
Abstract Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease, and in an effort to identify novel therapeutic target for this disease in recent years, human microbiota has attracted much interest. This paper briefly summarizes the main findings concerning the differences o...
| Huvudupphovsman: | |
|---|---|
| Materialtyp: | Artikel |
| Språk: | English |
| Publicerad: |
BMC
2020-02-01
|
| Serie: | Microbial Cell Factories |
| Ämnen: | |
| Länkar: | http://link.springer.com/article/10.1186/s12934-020-01313-4 |